SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

TTK Healthcare trades in green on the bourses

12 May 2017 Evaluate

TTK Healthcare is currently trading at Rs. 775.15, up by 0.90 points or 0.12% from its previous closing of Rs. 774.25 on the BSE.

The scrip opened at Rs. 835.00 and has touched a high and low of Rs. 835.00 and Rs. 772.30 respectively. So far 2255 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1110.00 on 12-Sep-2016 and a 52 week low of Rs. 768.00 on 02-May-2017.

Last one week high and low of the scrip stood at Rs. 835.00 and Rs. 768.10 respectively. The current market cap of the company is Rs. 601.98 crore.

The promoters holding in the company stood at 65.43%, while Institutions and Non-Institutions held 10.29% and 24.28% respectively.

Credit rating agency, ICRA has re-affirmed the long-term rating of ‘A+’ outstanding on the Rs 22.50 crore fund-based bank facilities of TTK Healthcare. The rating agency has also reaffirmed the short-term rating of ‘A1+’ outstanding on the Rs 6 crore fund-based facilities (sub limits), the Rs 4.75 crore non-fund based facilities and the Rs 0.25 crore proposed facilities of the company. The outlook on the long-term rating is stable.

TTK Healthcare commenced operations as a pharmaceutical company. Over the years, it diversified its presence across industries and its revenue sources were distributed across many product categories including contraceptives, gripe water, cosmetics, medical devices, home-care products, and food products.

TTK Healthcare Share Price

924.90 1.25 (0.14%)
24-Apr-2026 12:54 View Price Chart
Peers
Company Name CMP
Grasim Industries 2756.20
DCM Shriram 1192.40
3M India 32490.00
Hindustan Foods 488.95
Balmer Lawrie & Co 175.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×